Apyx Medical (APYX) Operating Leases (2019 - 2026)

Apyx Medical (APYX) has reported Operating Leases for 8 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 10.81% year-over-year to $3.8 million; the trailing twelve-month figure through Jun 2026 stood at $3.8 million (down 10.81% YoY), and the FY2025 full-year result was $4.1 million, down 9.64% from the prior year.
• Operating Leases eased to $3.8 million in Q2 2026 per APYX's latest filing, from $3.9 million in the prior quarter.
• Across five years, Operating Leases topped out at $5.4 million in Q2 2023 and bottomed at $448000.0 in Q1 2023.
• Historically, Operating Leases has averaged $3.6 million across 5 years, with a median of $4.3 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Operating Leases soared 2213.33% in 2022, then retreated 13.5% in 2024.
• Over 5 years, Operating Leases stood at $470000.0 in 2022, then surged by 941.7% to $4.9 million in 2023, then decreased by 8.44% to $4.5 million in 2024, then declined by 9.64% to $4.1 million in 2025, then dropped by 5.5% to $3.8 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $3.8 million, $3.9 million, and $4.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.